Peter Wohlmuth
Schwarzwald-Baar Klinikum, Asklepios Klinik St. Georg, Asklepios
Papers
5
Total Citations
134
H-Index
5
About
Dr. Peter Wohlmuth is a leading clinical researcher in cardiac electrophysiology, with a focused expertise in catheter ablation for atrial fibrillation (AF). His major contributions center on the comparative effectiveness and safety of emerging ablation technologies, particularly remote robotic navigation systems. Dr. Wohlmuth’s seminal 2012 work on silent cerebral lesions (SCL) after pulmonary vein isolation (PVI) provided critical safety data, demonstrating that robotic navigation could reduce the incidence of these subclinical brain injuries compared to manual ablation—a finding cited over 50 times and influencing procedural protocols. He further advanced the field through the "Man and Machine Trial" design, a prospective noninferiority study that systematically compared manual versus robotic approaches for AF treatment. His research consistently shows that robotic systems offer comparable long-term efficacy to manual techniques, with the added benefits of enhanced catheter stability and reduced operator radiation exposure. With cumulative citations exceeding 130, Dr. Wohlmuth’s work has helped establish robotic ablation as a viable, safer alternative for complex left atrial procedures, including isthmus line ablation. His studies underscore the principle that operator experience is paramount, even with advanced technology, guiding both clinical practice and future device development.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5